These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33308233)

  • 21. Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.
    Patorno E; Pawar A; Franklin JM; Najafzadeh M; Déruaz-Luyet A; Brodovicz KG; Sambevski S; Bessette LG; Santiago Ortiz AJ; Kulldorff M; Schneeweiss S
    Circulation; 2019 Jun; 139(25):2822-2830. PubMed ID: 30955357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of Provider and Practice Volume to Performance Measure Adherence for Coronary Artery Disease, Heart Failure, and Atrial Fibrillation: Results From the National Cardiovascular Data Registry.
    Fleming LM; Jones P; Chan PS; Andrei AC; Maddox TM; Farmer SA
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):48-54. PubMed ID: 26646817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loop diuretics in chronic heart failure: how to manage congestion?
    Simonavičius J; Knackstedt C; Brunner-La Rocca HP
    Heart Fail Rev; 2019 Jan; 24(1):17-30. PubMed ID: 30194516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
    Arnold SV; McGuire DK; Inzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
    J Diabetes Complications; 2018 Nov; 32(11):1035-1039. PubMed ID: 30177468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
    Heart; 2019 Aug; 105(16):1252-1259. PubMed ID: 30792238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study.
    Demant MN; Gislason GH; Køber L; Vaag A; Torp-Pedersen C; Andersson C
    Diabetologia; 2014 Aug; 57(8):1595-600. PubMed ID: 24849568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
    Cunha FM; Pereira J; Marques P; Ribeiro A; Bettencourt P; Lourenço P
    J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):21-26. PubMed ID: 31714331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes and heart failure: insights from the global DISCOVER study.
    Arnold SV; Khunti K; Bonnet F; Charbonnel B; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Luporini-Saraiva G; Medina J; Nicolucci A; Ramirez L; Shestakova MV; Shimomura I; Surmont F; Tang F; Vora J; Watada H; Kosiborod M;
    ESC Heart Fail; 2021 Apr; 8(2):1711-1716. PubMed ID: 33570253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.
    Khariton Y; Hernandez AF; Fonarow GC; Sharma PP; Duffy CI; Thomas L; Mi X; Albert NM; Butler J; McCague K; Nassif ME; Williams FB; DeVore A; Patterson JH; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004668. PubMed ID: 29627798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
    Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
    Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretic Responsiveness and Its Prognostic Significance in Children With Heart Failure.
    Price JF; Younan S; Cabrera AG; Denfield SW; Tunuguntla H; Choudhry S; Dreyer WJ; Akcan-Arikan A
    J Card Fail; 2019 Dec; 25(12):941-947. PubMed ID: 30986498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A perspective on diuretic resistance in chronic congestive heart failure.
    Shah N; Madanieh R; Alkan M; Dogar MU; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):271-278. PubMed ID: 28728476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
    Miyata M; Sasaki T; Ikeda Y; Shinsato T; Kubozono T; Furusho Y; Kusumoto A; Hamasaki S; Tei C;
    J Cardiol; 2012 May; 59(3):352-8. PubMed ID: 22365947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diuretic Response: Clinical and Hemodynamic Predictors and Relation to Clinical Outcome.
    Aronson D; Burger AJ
    J Card Fail; 2016 Mar; 22(3):193-200. PubMed ID: 26209003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of routine investigations to predict loop diuretic down-titration success in stable heart failure.
    Martens P; Verbrugge FH; Boonen L; Nijst P; Dupont M; Mullens W
    Int J Cardiol; 2018 Jan; 250():171-175. PubMed ID: 29056238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
    Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis.
    Lamblin N; Meurice T; Tricot O; de Groote P; Lemesle G; Bauters C
    J Card Fail; 2018 Dec; 24(12):815-822. PubMed ID: 30296582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.